New evidence supports revolutionary brain pacemaker.(Brief Article)
Publication: Medical Devices & Surgical Technology Week
Publication Date: 19-MAY-02
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
2002 MAY 19 - (NewsRx.com & NewsRx.net) -- Less than 7% of all Parkinson disease (PD) patients across Europe that could benefit from deep brain stimulation have benefited from the Activa Parkinson's Control Therapy, despite it being the most significant advance in the treatment of Parkinson's in more than 30 years.
The European Parkinson's Disease Association (EPDA) has announced new evidence on the current uptake of deep brain stimulation for Parkinson disease patients and despite its success there are still large numbers of patients waiting or denied access to the therapy.
Deep brain stimulation uses Medtronic's Activa Parkinson's Control Therapy which was launched by Medtronic...
Read the full article for free courtesy of your local library.
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
